MEDIPAN GMBH was founded in 1992 and is an independent, family company.
MEDIPAN started with the marketing of radioimmunoassays for the characterization of thyroid function, disease and tumor markers, with its partners from nuclear medicine laboratories, firstly within Germany. Later, the product portfolio expanded to include non-radioactive tests, and also tests to detect autoantibodies found in patients suffering from autoimmune type 1 diabetes. These diabetes antibody assays are now sold in more than 30 countries, from China to Chile.
MEDIPAN is an innovative and world renowned partner for laboratories and physicians, for the indications above and also in the fields of rheumatic and neurological disease.